Search our news archive and pharma companies…
|
Today's News | Note: News feeds may no longer be available for the articles on this page.
Glenmark
to Stop Sale of Painkiller Codeine Sulphate 4:56 AM 10/14/2009
Wall Street Journal
Glenmark Pharmaceuticals Ltd will stop distributing the pain reliever in the
US. The drug could be sold in the past without US FDA approval.
...
Medtronic
plans to study drug-coated stents for ED 2:32 PM 10/13/2009
Forbes
Medtronic Inc will test stents as a treatment for erectile dysfunction. The
company plans to implant the devices in the pelvic arteries of men where drugs like Cialis, Viagra, and Levitra
don't work.
...
Shire,
Sandoz settle litigation over generic Adderall XR 12:22 PM 10/13/2009
Bizjournals.com
Shire has settled all pending litigation regarding Sandoz's efforts
to market generic versions of attention deficit hyperactivity disorder drug Adderall XR.
...
New
Drug Could End Menstrual Cramps 5:55 AM 10/13/2009
ABC News
VA111913 manufactured by Vantia Therapeutics is in clinical trials in Britain and in
the US. The drug targets the cause of stomach cramps.
...
Vanda
Pharma, Novartis To Develop, Sell Schizophrenia Drug 4:06 PM 10/12/2009
Wall Street Journal
Vanda Pharmaceuticals Inc entered into an agreement with
Novartis AG to commercialize and develop its schizophrenia drug Fanapt in the US and Canada. Novartis expects to
launch in the US early next year.
...
Synta
Pharma cites new study data on cancer drug 3:33 PM 10/12/2009
Boston Globe
Synta Pharmaceuticals Inc said additional late-stage study data
reinforce the potential for its developing skin cancer drug elesclomol in combination with the cancer treatment
paclitaxel.
...
Depomed's hot
flashes drug data disappoints, shrs
dive 10:50 AM 10/12/2009
Reuters
Depomed
Inc's experimental drug Serada to treat menopausal hot flashes showed disappointing results in two late-stage
trials.
...
Onyx
to Buy Proteolix for $276 Million, Gaining a Cancer
Drug 7:30 AM 10/12/2009
Bloomberg
Onyx
Pharmaceuticals Inc will pay $276 million for Proteolix Inc to gain an experimental blood-cancer drug carfilzomib
and expand its offerings beyond tumor fighter Nexavar.
...
FDA
and Glaxo warn of death with anti-flu drug 5:19 PM 10/9/2009
Forbes
GlaxoSmithKline notified doctors of at least one death when anti-flu
medication Relenza was reformulated into a liquid form. Relenza comes in powder form for use with Glaxo's
Diskhaler device.
...
Pfizer
Halts Enrollment In Lung-Cancer Drug Trial 2:52 PM 10/9/2009
Wall Street Journal
Pfizer Inc temporarily halted enrollment of new patients in a
Phase 3 clinical trial of experimental lung-cancer drug CP-751,871 (figitumumab). It was associated with a
higher rate of adverse events including fatalities.
...
Allergic
reaction to vaccines should be investigated 1:02 PM 10/9/2009
Los Angeles Times
When a serious reaction occurs the patient should be evaluated by
an allergist. Vaccine components include gelatin or egg protein, yeast, latex from the syringe plungers,
neomycin, and thimerosal.
...
Susceptible
to Swine Flu but Skipping Inoculations 12:53 PM 10/9/2009
New York Times
Students from elementary and high school did the worst in having seasonal flu
shots last year. That's the age group most likely to become infected with swine flu.
...
J&J
wheels and deals, awaits new product approvals 10:18 PM 10/9/2009
BusinessWeek
J&J is awaiting possible US approvals for its Pinnacle Complete hip
implant system, Xarelto pill to prevent blood clots, and the antibiotic ceftobiprole for complicated skin
infections like MRSA.
...
Avanir
drug shows promise for MS-related pain 10:08 PM 10/9/2009
Reuters
Avanir Pharmaceuticals Inc said a late-stage trial of its neurological drug Zenvia
showed encouraging proof of concept data in relieving pain associated with multiple sclerosis (MS).
...
US
FDA staff: limited effect with Acorda MS drug 8:35 AM 10/9/2009
Reuters
Acorda Therapeutics Inc's proposed brand drug Amaya to help multiple
sclerosis patients walk better met its main clinical trial goals but had a 'very limited effect'.
...
<- Day Earlier | Today's News
|
